Urgent Recall: Diabetes Supplement CuraLin Poses Seizure and Coma Risks Due to Incorrect Usage
2025-05-05
The Straits Times
The Health Sciences Authority (HSA) has issued a recall for the diabetes supplement CuraLin after detecting a significant risk of seizures and coma if taken incorrectly. Tests conducted on the capsules revealed that they contained two prescription-on ...Read more
